ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

TeleVox Showcases Latest Patient Relationship Management Innovations at HLTH 2024

LAS VEGAS, Oct. 16, 2024 (GLOBE NEWSWIRE) -- TeleVox, the industry-leading provider of omnichannel patient relationship management (PRM) platforms, is showcasing the latest innovations in its suite of payer, pharmaceutical, and enterprise patient engagement solutions at the HLTH annual conference, October 20-23 in Las Vegas. Visitors to TeleVox’s booth #4043 will learn about robust features introduced over the past year, from AI-driven SMART SMS to the readmission-reducing Digital Care Programs, and expanded Agent Chat functionality.

TeleVox Showcases Latest Patient Relationship Management Innovations at HLTH 2024

The HLTH conference is the preeminent event for healthcare innovation, where more than 12,000 leaders gather to pioneer a healthier future through dynamic partnerships and transformative ideas. Attendees will have the opportunity to hear about the latest technology in the health industry, discuss the future of healthcare, explore ways to accelerate innovation, and learn how partnering with evidence-based technologies can support business goals.

“The audience that will be drawn to Las Vegas for the HLTH conference is one that will appreciate the cutting-edge nature of the patient relationship management technology we’ve rolled out and expanded this year,” said Hilary Cooper, Head of Marketing at TeleVox. “For example, our SMART SMS utilizes conversational AI responses to provide continuing conversations within the same channel for patient conversations. Platforms like this one offer unprecedented modern value to the health system and their patients – a future-proof response to the demands of a rapidly changing industry.”

Learn more about the conference or get in touch to arrange a brief meeting with a TeleVox expert during the show.

About TeleVox
TeleVox is a leading provider of omnichannel digital patient relationship management technology. Our solutions are trusted by more than 7,000 healthcare organizations, including hospitals, health systems, and community health centers, to engage, educate, and empower patients throughout their care journey. Our patient relationship management platform integrates seamlessly with the electronic health record (EHR) to support automated, personalized, two-way interactions with patients. Additionally, our pharmaceutical team partners with life science companies to develop strategic disease state awareness, education, and vaccination reminders, reaching more patients through customized communication. All of these exchanges are made possible via text, virtual assistant, interactive voice response (IVR), email, and postcards. For 30 years, TeleVox has helped preserve care continuity, reduce the operational burden on staff, and drive revenue, making the healthcare communication process easier for everyone. TeleVox is part of West Technology Group, LLC, controlled by affiliates of certain funds managed by Apollo Global Management, Inc. (NYSE: APO).

For more information, please visit www.televox.com.

Contact
Donald Thompson
Head of Marketing
Donald.thompson@televox.com
(315) 720-3304

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b3b3623c-43c1-4193-9b4c-f1fdd61792e2


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.